Investigators from Nanyang Technological University Zero in on Cancer Vaccines (Metal-organic Framework-based Nanovaccine for Relieving Immunosuppressive Tumors Via Hindering Efferocytosis of Macrophages and Promoting Pyroptosis and Cuproptosis ...)

媒體報導

• 標題	Investigators from Nanyang Technological University Zero in on Cancer Vaccines (Metal-organic Framework-based Nanovaccine for Relieving Immunosuppressive Tumors Via Hindering Efferocytosis of Macrophages and Promoting Pyroptosis and Cuproptosis ...)
  媒體名稱/出口	Vaccine Daily
  國家/地區	United States
  日期	14/06/24
  人員	JINGJING GUO